Chairman’s Corner

Hans Schambye, 2020-2022

CEO – Md, PhD Medical Sciences
Galecto, Inc.

  • Served as Chief Executive Officer of ReceptIcon from 2006 to 2009 and as CEO of Gastrotech Pharma A/S from 2004 to 2006
  • Served as Director of Biology and Pharmacology and Head of Portfolio Management at Maxygen, a US biotech company
  • Hans has co-founded several biotech companies, including ProFound Pharma A/S, a Danish biotech company, which was acquired by Maxygen in 2000
  • Prior to this he had a successful research career at Stanford University and Copenhagen University within the field of receptor biology


    If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 5150 0560

    Copyright 2010 Danskbiotek. All rights reserved.